A detailed history of Quadcap Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Quadcap Wealth Management, LLC holds 12,389 shares of ABBV stock, worth $2.19 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
12,389
Previous 11,032 12.3%
Holding current value
$2.19 Million
Previous $1.89 Billion 29.27%
% of portfolio
0.38%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $222,330 - $270,490
1,357 Added 12.3%
12,389 $2.45 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $67,488 - $78,811
436 Added 4.11%
11,032 $1.89 Billion
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $56,576 - $64,463
-354 Reduced 3.23%
10,596 $1.93 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.51 Million - $1.7 Million
10,950 New
10,950 $1.7 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Quadcap Wealth Management, LLC Portfolio

Follow Quadcap Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadcap Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadcap Wealth Management, LLC with notifications on news.